Lipid metabolism

Dr. McMillan is an advocate for putting patient voices at the absolute center of clinical research, fundamentally changing how treatments are developed.

He is currently mapping uncharted territories in neurotrauma, from investigating how spinal injuries alter fat metabolism to pioneering research on the physiological risks and rewards of using psychedelics for severe nerve pain and spasticity.

Fresh off a Senate briefing advocating for accelerated FDA approvals for emerging combinatorial therapies like NVG291, he is here to discuss the true frontier of SCI research and the relentless collaborative pursuit of a cure.

Stay tuned.